The 20Sense Report, a quarterly publication for Canada’s specialty pharmaceutical industry, featured VeraSci’s Dr. Luca Pani in their April 2021 issue discussing creative approaches to market access. The article compares the agreements that have been used in Italy to what could be done for Canada. During Dr. Pani’s time as Director General of the Italian Medicine Agency, he made Italy a leader in managed entry and outcome-based agreements. The article discusses many issues common to market access for gene therapy and other advanced therapies, including demonstrating duration of effect, the use of registries and value endpoints, and early access mechanisms.

Download the full report here.